Health

Is It Time to End Animal Testing?

Is It Time to End Animal Testing?

Scholars recommend regulators promote alternatives to experiments conducted on animals.

FDA’s Minimal Authority over Dietary Supplements

FDA’s Minimal Authority over Dietary Supplements

Scholars urge Congress to give FDA more power to regulate dietary supplements.

Cutting Corners on COVID-19 Treatments?

Cutting Corners on COVID-19 Treatments?

Scholars analyze FDA’s emergency use authorizations during the COVID-19 pandemic.

How States Can Improve Contraceptive Access

How States Can Improve Contraceptive Access

A recent report proposes state-level reforms to allow pharmacists to prescribe contraceptives.

Regulating Junk Food Marketing

Regulating Junk Food Marketing

Scholars critique the scarcity of regulation surrounding food marketing to children.

Does Industry Self-Regulation of Mental Health Apps Protect Consumers?

Does Industry Self-Regulation of Mental Health Apps Protect Consumers?

Scholar advocates increased regulation of mental health apps.

Regulating Physician-Assisted Death

Regulating Physician-Assisted Death

Scholar analyzes the relation between federal regulation and assisted death initiatives.

Intermediaries in the Drug-Price War

Intermediaries in the Drug-Price War

Experts debate the role of pharmacy benefit managers in rising U.S. drug prices.

Cleaning Up “Clean” Food Labeling

Cleaning Up “Clean” Food Labeling

Scholars propose avenues to improving the regulation of clean food labels.

The Fatal Flaws in the “Abortion Pill” Decision

The Fatal Flaws in the “Abortion Pill” Decision

By second-guessing FDA safety determinations, the Fifth Circuit challenges the Supreme Court to restore agency deference.

Small-Scale Solutions to the Large-Scale Drug Crisis

Small-Scale Solutions to the Large-Scale Drug Crisis

Expert advocates a variety of policies that local governments can take to combat increasing fatalities from drug overdoses.

How Patents Contribute to High Drug Prices

How Patents Contribute to High Drug Prices

Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.